Bluejay Diagnostics (BJDX) EPS (Basic) (2022 - 2023)
Bluejay Diagnostics (BJDX) has disclosed EPS (Basic) for 2 consecutive years, with -$3573.1 as the latest value for Q4 2023.
- Quarterly EPS (Basic) fell 151302.54% to -$3573.1 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was -$3614.3 through Dec 2023, down 48741.35% year-over-year, with the annual reading at -$15.25 for FY2025, 96.66% up from the prior year.
- EPS (Basic) hit -$3573.1 in Q4 2023 for Bluejay Diagnostics, down from -$16.67 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.1 in Q1 2022 to a low of -$3573.1 in Q4 2023.